Dr. Reza Moradi, MD

Dr. Moradi practices at Eyeconic Medical in Long Beach, California.

Dr. Moradi's NPI, 1851773527, was assigned on June 18, 2015. Dr. Moradi graduated from Shahid Beheshti University of Medical Sciences in 2009. Dr. Moradi holds California license 157047.

Dr. Moradi's primary practice is Eyeconic Medical, at 3800 Kilroy Airport Way, Long Beach, CA 90806 in Los Angeles County. The practice phone is (949) 270-6063.

Dr. Moradi's primary practice is Eyeconic Medical in Long Beach, California. Dr. Moradi is also affiliated with Hoag Hospital Newport Beach. The medical group on file is City of Hope. Dmand AI also links Dr. Moradi to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moradi practices, 3 sites in all. Vendor and product names are available with a free account.

Cornea and external diseases specialist is Dr. Moradi's primary specialty in the NPI Registry, under taxonomy code 207WX0120X. Dr. Moradi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Moradi's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and inflammation of iris among the conditions Dr. Moradi treats.

CMS data shows 862 Medicare services from Dr. Moradi across 11 procedure codes in 2024, for 154 Medicare patients. Medicare paid $55,950 for them.

CMS counts 154 Medicare patients who saw Dr. Moradi in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moradi's median patient age at 64, with 57% women.

In 2024, Dr. Moradi wrote 405 Medicare Part D claims for 126 patients. 49% of them were for generic drugs. CMS names the drug for 336 of them, across 10 drugs with 11 or more claims each, at $33,708 in total drug cost. In 2023, CMS named 415 claims across 13 drugs.

Dr. Moradi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of cataract surgery by Dr. Moradi, more than 70% of the clinicians it reports for that procedure.

CMS Open Payments shows 100 general payments to Dr. Moradi from 22 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 63% of the total. Tarsus Pharmaceuticals, Inc. paid the most, $5,286.

Dr. Moradi graduated from Shahid Beheshti University of Medical Sciences in 2009. Dr. Moradi is a member of AAO, ACP, ACS, AMA, ASCRS and European Society of Cataract and Refractive Surgery (ESCRS).

Dr. Moradi is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.